EVLO

Evelo Biosciences Announces Grant of Inducement Award

Evelo Biosciences Announces Inducement Award Plan for Expanding Leadership Team

Evelo Biosciences: Monoclonal Microbes Offer Novel Inflammatory Treatment With A Favorable Risk-Reward Profile

Evelo Biosciences, Inc (EVLO) CEO Simba Gill on Q1 2021 Results - Earnings Call Transcript

Evelo Biosciences to Present at 20th Annual Needham Virtual Healthcare Conference

Evelo Biosciences & Abdul Latif Jameel Health Announce Strategic Collaboration to Develop & Commercialize Novel Therapy EDP1815 for Inflammatory Diseases & COVID-19 in Select Developing Markets Serving 1.7 Billion People

Evelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q4 2020 Results - Earnings Call Transcript